Patent intelligence · US
US 10279176
Method and apparatus for increasing absorption of medications and cosmeceuticals through the skin of the user
Method and apparatus for increasing absorption of medications and cosmeceuticals through the skin of the user
Patent details — US 10279176
- Jurisdiction
- US
- Status
- granted
- Grant date
- May 7, 2019
- Expiration
- May 2, 2039
- Applicant
- FIRST STEP HOLDINGS, LLC
- Claims
- 19
- CPC classes
- A61K, A61K9/0014
Quick answer
US 10279176 (Method and apparatus for increasing absorption of medications and cosmeceuticals through the skin of the user) is held by FIRST STEP HOLDINGS, LLC. Status: granted. Granted May 7, 2019. Expires May 2, 2039 (13 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- FIRST STEP HOLDINGS, LLC
- Grant date
- Expiration
- Claims
- 19
- CPC classes
- A61K, A61K9/0014
More from FIRST STEP HOLDINGS, LLC
Related pharmaceutical patents in our USPTO index.
-
US 12357666
Traditional Chinese herbal plant composition for improving symptoms of liver cancer patients and compatibility method thereof
granted -
US 12228572
Enhanced expression of polo-like kinase 3 (PLK3) in human immunodeficiency virus (HIV)-infected cells
granted -
US 12220446
Use of upstream open reading frame 45aa-uORF nucleotide sequence of PTEN gene and polypeptide coded by 45aa-uORF
granted -
US 12090156
Application of CB-839 in preparation of drug for inhibiting corneal neovascularization (CNV)
granted -
US 12076443
Preparation method of nanozyme composite-based hybrid hydrogel eye drop
granted -
US 12016950
Devices and methods for treating ear pain
granted -
US 11992555
Solid solution compositions and use in chronic inflammation
granted -
US 11980602
Cannabinoid prodrug compounds
granted
Frequently asked questions
What is US patent 10279176?
US 10279176 (Method and apparatus for increasing absorption of medications and cosmeceuticals through the skin of the user) is held by FIRST STEP HOLDINGS, LLC. Status: granted. Granted May 7, 2019. Expires May 2, 2039 (13 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 10279176?
FIRST STEP HOLDINGS, LLC is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 123 pharmaceutical patents for this assignee.
When does US 10279176 expire?
Our index shows an expiration date of May 2, 2039 (13 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.